Association study of copy number variants with brain volume in schizophrenia patients and healthy controls  by Terwisscha van Scheltinga, Afke et al.
Psychiatry Research 200 (2012) 1011–1013Contents lists available at SciVerse ScienceDirectPsychiatry Research0165-17
http://d
n Corr
E-m
S.Bakke
N.E.M.v
J.E.Buize
H.B.M.B
W.Cahn
rophoffjournal homepage: www.elsevier.com/locate/psychresBrief reportAssociation study of copy number variants with brain volume in
schizophrenia patients and healthy controlsAfke Terwisscha van Scheltinga a,n, Steven Bakker a, Neeltje van Haren a,
Jacobine Buizer-Voskamp a, Heleen Boos a, Jacob Vorstman a,b, Wiepke Cahn a,
Hilleke Hulshoff Pol a, Roel Ophoff b, Rene´ Kahn a
a Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Huispostnummer A00.241, Heidelberglaan
100, 3584 CX, Utrecht, the Netherlands
b Centre for Neurobehavioral Genetics, University of California, Los Angeles, United States of Americaa r t i c l e i n f o
Article history:
Received 3 January 2012
Received in revised form
31 March 2012
Accepted 9 April 2012
Keywords:
Imaging
Deletion
Duplication81& 2012 Elsevier Ireland Ltd.
x.doi.org/10.1016/j.psychres.2012.04.007
esponding author. Tel.: þ31 88 755 5555; fax
ail addresses: aterwiss@umcutrecht.nl (A. Ter
r-2@umcutrecht.nl (S. Bakker),
anHaren@umcutrecht.nl (N. van Haren),
r@umcutrecht.nl (J. Buizer-Voskamp),
oos@umcutrecht.nl (H. Boos), J.A.S.Vorstman@
@umcutrecht.nl (W. Cahn), H.E.Hulshoff@um
@mednet.ucla.edu (R. Ophoff), R.Kahn@umcu
Open access unda b s t r a c t
Schizophrenia patients have more copy number variations (CNVs) than healthy controls, and reduced
brain volumes. Although this could suggest a causal relationship, we found no association between
global CNV burden and three brain volume measures (on a MRI scan) in a sample of 173 schizophrenia
patients and 176 healthy controls.
& 2012 Elsevier Ireland Ltd. Open access under the Elsevier OA license.1. Introduction
The heritability of schizophrenia is around 80% (Cardno et al.,
1999), but the underlying genetic determinants are largely
unknown. Copy number variants (CNVs) are genomic microdele-
tions or microduplications from 1 kb to multiple Mb in size. These
can disrupt genes and thereby change mRNA and protein levels,
possibly resulting in disease (Sutrala et al., 2007). An excess of rare
CNVs was found in schizophrenia (15%) compared to healthy
controls (5%) (Walsh et al., 2008). Our group previously reported a
signiﬁcantly higher burden of deletions in schizophrenia patients
compared to healthy controls (Buizer-Voskamp et al., 2011). Several
speciﬁc deletions related to schizophrenia, e.g. on chromosome
location 1q21.1 and 22q11, were previously shown to be associated
with neuroanatomical abnormalities such as reduced total brain
volumes (Brunetti-Pierri et al., 2008;Zinkstok and Amelsvoort,
2005). Total brain volume is highly heritable (80–90%) (Baare
et al., 2001) and patients with schizophrenia have on average 3%
smaller brain volumes compared to healthy controls (Wright et al.,: þ31 88 755 5466.
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er the Elsevier OA license.2000). Investigating the genetic factors underlying brain volume
reductions can increase insight into the pathophysiology of schizo-
phrenia. Our group previously reported that white matter loss in
schizophrenia patients was largely (94%) attributable to genetic
factors, while gray matter volume was determined by unique and
common environmental factors (Haren et al., in press). We therefore
investigated the association between global CNV burden and total
brain, white matter and gray matter volume in schizophrenia
patients and healthy controls.2. Methods and materials
2.1. Subjects
The sample consisted of 173 patients (158 with schizophrenia, and 15 with
schizoaffective disorder) and 176 controls. Psychopathology was assessed using
the Comprehensive Assessment of Symptoms and History (Andreasen et al., 1992).
Unaffected subjects had no history of psychiatric illness except for three subjects
who had a history of anxiety disorder, obsessive-compulsive disorder and
adjustment disorder. None of the control subjects had ﬁrst-degree family mem-
bers with psychotic illness.
2.2. Magnetic resonance imaging
Brain images were acquired on Philips NT and Philips Achieva scanners at
1.5 T. MRI acquisition and processing methods have been previously described
(Hulshoff Pol et al., 2002). Post-processing was done on the neuro-imaging
computer network at our department. Images were coded to ensure blind
measurements. Total brain, white matter and gray matter volume were corrected
Table 1
Association results of CNVs with brain volumes. P main is the effect of the CNV in the total sample. P interaction is the interaction with disease status, which is equivalent to
the difference in effect in the patient and control groups. P-values are not corrected for multiple testing.
P main
total brain
P interaction
total brain
P main
white matter
P interaction
white matter
P main
gray matter
P interaction
gray matter
CNVs containing genes 0.15 0.28 0.56 0.79 0.07 0.07
Genes in CNVs 0.88 0.29 0.90 0.51 0.50 0.66
Brain genes in CNVs 0.98 0.19 0.66 0.21 0.66 0.61
Deletions containing genes 0.02 0.58 0.14 0.28 0.64 0.13
Genes in deletions 0.09 0.04 0.44 0.07 0.13 0.07
Brain genes in deletions 0.56 0.26 0.98 0.02 0.39 0.04
Duplications containing genes 0.24 0.19 0.53 0.31 0.34 0.09
Genes in duplications 0.69 0.54 0.89 0.52 0.66 0.30
Brain genes in duplications 0.48 0.47 0.80 0.73 0.62 0.03
A. Terwisscha van Scheltinga et al. / Psychiatry Research 200 (2012) 1011–10131012for intracranial volume, age and sex by taking the unstandardized residuals using
linear regression.
2.3. Genotyping
Subjects were genotyped at the University of California in Los Angeles on the
Illumina HumanHap550 beadchip. CNVs were determined from SNP data using
the QuantiSNP and PennCNV algorithms as described previously (Buizer-Voskamp
et al., 2011). Deviations for 10 consecutive SNPs were regarded as CNVs. Refseq
genes within 50 kb of the CNV borders were counted using the March 2006
assembly on the UCSC browser (http://genome.ucsc.edu). Brain expression was
determined using expressed sequence tag data of brain tissue in the UCSC
browser. Total numbers of CNVs affecting genes, genes affected by CNVs and
brain expressed genes affected by CNVs were calculated.
2.4. Statistical analyses
Above a certain cut-off point (3þ , 4þ or 5þ , depending on the frequency
distribution) numbers of CNVs were combined to obtain categories of at least 20
subjects (see Supplementary Table 1). First, the 3 CNV measures were used as
factors (one-by-one) in ANOVAs with the unstandardized residuals of the brain
volume measures as dependent variables in the total sample. Second, to study if
the impact of CNVs on brain volume differs between patients and controls, disease
status and CNVndisease status interaction were included in the analyses. All
analyses were repeated for deletions and duplications separately.3. Results
There were signiﬁcantly more males in the patient group than in
the control group (80% vs. 54% male, po0.0001). The groups did not
differ in age and parental education (an estimate for socioeconomic
status). Total brain volume was signiﬁcantly smaller in patients
(mean 1482.1 ml, sd 50.8) than in controls (mean 1505.4 ml, sd
43.7; p¼5.3106), as were gray matter and white matter volume.
After correction for multiple comparisons (a¼0.003 (¼0.05/18 (3
brain volumes3 ‘independent’ CNV measures2 tests))), none of
the CNV measures showed a signiﬁcant association with total brain
volume, as shown (Table 1).4. Discussion
The results suggest that global CNV burden does not exert
major effects on brain volume in schizophrenia patients nor in
healthy controls. We had 80% power to detect a CNV measure
explaining 4.3% of the variance in total brain volume with a 0.003.
Although the effect of CNVs might be larger than the effect of
SNPs and quantitative phenotypes have more power than dichot-
omous disease traits (Potkin et al., 2009), the combined effects of
CNVs may still have been too small to detect in our sample. If only
a limited number of speciﬁc CNVs have an impact on brain
development, these could be missed by analyzing global CNV
burden. Alternatively, CNVs might have regional effects on brain
volume that could go undetected by using global brain volumemeasures. Replication of this negative ﬁnding is essential, and for
this purpose our raw data are available on request. Should
replication studies also fail to demonstrate an association
between CNV burden and brain volume, another possible expla-
nation is that CNVs and brain volume are independently asso-
ciated with schizophrenia, or that at least one of them is
associated to schizophrenia through a confounder.Acknowledgments
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